Financial statements Apopharma

Balance sheet of Apopharma

Company age:
Age:
14 y. 7 m. 23 d.
Share capital:
Share capital:
5 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of APOPHARMA

Year
2018
2019
2020
2021
2022
2023
Total assets 3 864 114,92 4 377 305,09 3 632 656,61 3 631 391,75 4 167 066,39 4 647 597,59
A. Fixed assets 88 725,34 875 421,30 757 895,43 691 702,91 615 212,74 570 926,84
B. Current assets 3 775 389,58 3 501 883,79 2 874 761,18 2 939 688,84 3 551 853,65 4 076 670,75
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00 0,00
Total liabilities 3 864 114,92 4 377 305,09 3 632 656,61 3 631 391,75 4 167 066,39 4 647 597,59
A. Equity -1 932 267,59 -4 500 413,71 -5 103 091,70 -5 558 097,71 -6 284 111,07 -7 472 838,55
B. Liabilities and provisions for liabilities 5 796 382,51 8 877 718,80 8 735 748,31 9 189 489,46 10 451 177,46 12 120 436,14
I. Long-term liabilities 0,00 0,00 0,00 0,00 0,00 0,00
II. Short-term liabilities 4 610 714,94 8 601 615,76 8 578 890,45 9 032 343,13 10 156 088,30 11 849 908,93
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.